News
As state and federal legislation in the US and elsewhere tries to catch up with the digital health economy, the patient at the center of that economy might struggle to know just how private their data actually is.
Industry groups including AHIP, MGMA and the AMA support the patient access aims of the final regs, but have qualms about third-party developers and the compliance burden for providers.
The technology, called Locate Mask, is designed to facilitate compliant data sharing without diminishing its value, according to the vendor – improving innovation and analytics potential.
Facebook, Google and Twitter take action to ensure accurate health advice on their platforms.
On March 9, the Innovation and Technology Commission (ITC) in Hong Kong launched a special call under the Public Sector Trial Scheme for projects to support product development and application of technologies for the prevention and control of COVID-19.
WHAT’S IT ABOUT
The special round aims to fund trials of R&D outcomes in the local public sector relating to detection, diagnosis or surveillance of the COVID-19 virus, or reduction of the risks of infection and its spread. According to its official release, the R&D outcomes should be immediately ready for trials by government departments or the relevant public organizations to bring about benefits for the community in fighting the epidemic in the near future.
The target funding recipients are local R&D centers, universities and other designated public research institutes, as well as all technology companies conducting R&D activities in Hong Kong. The funding ceiling for each project is HKD $2M in general, and a higher ceiling for individual projects may be considered if necessary and justified.
Applications will be accepted from now until April 10, and more details are available here.
THE LARGER TREND
Last week, Singapore-born, Boston-based digital therapeutics startup Biofourmis announced that its technology is being utilized in a remote monitoring and disease surveillance program in Hong Kong involving patients with diagnosed or suspect cases of COVID-19. The program is being administered by the University of Hong Kong.
Elsewhere in APAC, governments or public agencies are collaborating with healthtech startups to tackle the management and/or diagnosis of COVID-19. Singapore’s national HIT agency, IHiS, has worked with local healthcare AI startup Kronikare to pilot iThermo – an AI-powered temperature screening solution that screens and identifies those having or showing symptoms of fever, HealthcareITNews reported.
Singapore-based Veredus Laboratories worked with the Home Team Science and Technology Agency (HTX), a statutory board under the Ministry of Home Affairs, to develop its VereCoV Detection Kit, a portable Lab-on-Chip application capable of detecting the 2019 Novel Coronavirus (COVID-19) in a single test, according to MobiHealthNews report.
ON THE RECORD
“The aim of the call is not only to promote the realization and commercialization of local R&D outcomes, but also to encourage the public sector to use technologies for tackling the COVID-19 epidemic in Hong Kong, thereby bearing dual significance,” said an ITC spokesman in a statement.
National Coordinator Don Rucker and Deputy National Coordinator Steve Posnack talk enforcement timelines, "content and manner," FHIR 4, gag clause provisions, patient privacy and more.
Mobile app equipped with social media and telemedicine designed to keep patients in recovery connected with their clinical-care teams and support networks after discharge.
The goal is to empower healthcare and life sciences organizations of all types and sizes to deliver more personalized and collaborative experiences at scale.
Hospitals and group practices can obtain the patient texting technology at no cost to help protect their caregivers and patients from unnecessary contact.
The companies want to break down barriers to delivering care related to technology.